EORTC-NCI-AACR International Symposium on Molecular Targets and Cancer Therapeutics
Symposium - Dublin, Ireland
Hosted by the European Organisation for Research and Treatment of Cancer, the National Cancer Institute and the American Association for Cancer Research, the 2012 Symposium will bring together over 2,000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.
During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomised, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information. For these reasons, the Symposium has been organised to ensure the maximum amount of interaction and discussion through an exciting range of plenary sessions and lively workshops.
(Courtesy of http://www.aacr.org/AACRmeetings)
Tue, Nov 06, 2012 - Fri, Nov 09, 2012
Convention Centre Dublin (CCD), Dublin, Ireland
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
